These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37515398)

  • 1. Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas.
    Zhang X
    IET Syst Biol; 2023 Oct; 17(5):259-270. PubMed ID: 37515398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding meningioma heterogeneity and neoplastic cell-macrophage interaction through single-cell transcriptome profiling across pathological grades.
    Fan H; Song L; Fan J; Ma J; Li X; Zhang J; Hu J; Wu Z; Zhang D; Wang L
    J Transl Med; 2023 Oct; 21(1):751. PubMed ID: 37880655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome signatures associated with meningioma progression.
    Viaene AN; Zhang B; Martinez-Lage M; Xiang C; Tosi U; Thawani JP; Gungor B; Zhu Y; Roccograndi L; Zhang L; Bailey RL; Storm PB; O'Rourke DM; Resnick AC; Grady MS; Dahmane N
    Acta Neuropathol Commun; 2019 Apr; 7(1):67. PubMed ID: 31039818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell hdWGCNA reveals metastatic protective macrophages and development of deep learning model in uveal melanoma.
    Sun Y; Wu J; Zhang Q; Wang P; Zhang J; Yuan Y
    J Transl Med; 2024 Jul; 22(1):695. PubMed ID: 39075441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
    Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
    Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas.
    Chang X; Shi L; Gao F; Russin J; Zeng L; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Wang K; Mack WJ
    Neurosurg Focus; 2013 Dec; 35(6):E3. PubMed ID: 24289128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Transcriptomic Analysis Reveals the Molecular Mechanism of Meningiomas by Weighted Gene Coexpression Network Analysis.
    Yang B; Wei S; Ma YB; Chu SH
    Biomed Res Int; 2020; 2020():4927547. PubMed ID: 32596316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
    Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
    Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq.
    Huang M; Xu S; Li Y; Shang L; Zhan X; Qin C; Su J; Zhao Z; He Y; Qin L; Zhao W; Long W; Liu Q
    Adv Sci (Weinh); 2023 May; 10(15):e2205525. PubMed ID: 36994665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningioma transcription factors link cell lineage with systemic metabolic cues.
    Du Z; Brewster R; Merrill PH; Chmielecki J; Francis J; Aizer A; Abedalthagafi M; Sholl LM; Geffers L; Alexander B; Santagata S
    Neuro Oncol; 2018 Sep; 20(10):1331-1343. PubMed ID: 29660031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in
    Adams CL; Ercolano E; Ferluga S; Sofela A; Dave F; Negroni C; Kurian KM; Hilton DA; Hanemann CO
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration.
    Teranishi Y; Miyawaki S; Nakatochi M; Okano A; Ohara K; Hongo H; Ishigami D; Sakai Y; Shimada D; Takayanagi S; Ikemura M; Komura D; Katoh H; Mitsui J; Morishita S; Ushiku T; Ishikawa S; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2023 Sep; 11(1):156. PubMed ID: 37752594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
    Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
    Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-
    Fu XH; Li JP; Li XY; Tan Y; Zhao M; Zhang SF; Wu XD; Xu JG
    J Immunol Res; 2022; 2022():8326591. PubMed ID: 35637794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma.
    Chen J; Hua L; Xu X; Jiapaer Z; Deng J; Wang D; Zhang L; Li G; Gong Y
    World Neurosurg; 2023 Aug; 176():e501-e514. PubMed ID: 37263494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
    Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
    J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
    Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
    Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.